Posted on February 22, 2021 by adminUS-based NeoImmuneTech eyes W96b IPO in Korea NeoImmuneTech, a US immunotherapy drug development company, said Monday that it was looking to raise as much as 96 billion won ($86.9 million) in fresh funds via an initial public offering on the … ( read original story …)